PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.06%
Negative revenue growth while 1113.HK stands at 20.30%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-8.23%
Negative gross profit growth while 1113.HK is at 16.23%. Joel Greenblatt would examine cost competitiveness or demand decline.
-22.68%
Negative EBIT growth while 1113.HK is at 12.20%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-72.83%
Negative operating income growth while 1113.HK is at 27.36%. Joel Greenblatt would press for urgent turnaround measures.
-42.27%
Negative net income growth while 1113.HK stands at 18.11%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-42.34%
Negative EPS growth while 1113.HK is at 19.01%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-42.22%
Negative diluted EPS growth while 1113.HK is at 19.01%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.08%
Slight or no buybacks while 1113.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.01%
Slight or no buyback while 1113.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Dividend reduction while 1113.HK stands at 328.23%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-63.88%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-80.46%
Negative FCF growth while 1113.HK is at 6.63%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
47013.22%
10Y revenue/share CAGR above 1.5x 1113.HK's 223.11%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
313.21%
5Y revenue/share CAGR above 1.5x 1113.HK's 56.82%. David Dodd would look for consistent product or market expansions fueling outperformance.
30.64%
Positive 3Y CAGR while 1113.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
159.90%
Positive long-term OCF/share growth while 1113.HK is negative. John Neff would see a structural advantage in sustained cash generation.
185.52%
Positive OCF/share growth while 1113.HK is negative. John Neff might see a comparative advantage in operational cash viability.
-62.94%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
603.05%
Net income/share CAGR above 1.5x 1113.HK's 54.02% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
130.57%
Positive 5Y CAGR while 1113.HK is negative. John Neff might view this as a strong mid-term relative advantage.
-57.34%
Negative 3Y CAGR while 1113.HK is 187.80%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
0.64%
Below 50% of 1113.HK's 1749.72%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
16.51%
5Y equity/share CAGR at 75-90% of 1113.HK's 21.93%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
7.76%
3Y equity/share CAGR at 50-75% of 1113.HK's 15.20%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-100.00%
Cut dividends over 10 years while 1113.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.95%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
180.97%
Positive asset growth while 1113.HK is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
No Data
No Data available this quarter, please select a different quarter.
-10.30%
We’re deleveraging while 1113.HK stands at 1.33%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.33%
We cut SG&A while 1113.HK invests at 3.67%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08